DK138581B - Fremgangsmåde til fremstilling af en virus-underenhedsvaccine stammende fra et æterfølsomt virus. - Google Patents
Fremgangsmåde til fremstilling af en virus-underenhedsvaccine stammende fra et æterfølsomt virus.Info
- Publication number
- DK138581B DK138581B DK543974AA DK543974A DK138581B DK 138581 B DK138581 B DK 138581B DK 543974A A DK543974A A DK 543974AA DK 543974 A DK543974 A DK 543974A DK 138581 B DK138581 B DK 138581B
- Authority
- DK
- Denmark
- Prior art keywords
- virus
- ether
- producing
- subunit vaccine
- sensitive
- Prior art date
Links
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 title 2
- 241000700605 Viruses Species 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940031626 subunit vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB48685/73A GB1486557A (en) | 1973-10-18 | 1973-10-18 | Process for the preparation of pyrogen-free sub-unit vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK543974A DK543974A (enExample) | 1975-06-16 |
| DK138581B true DK138581B (da) | 1978-10-02 |
| DK138581C DK138581C (enExample) | 1979-03-12 |
Family
ID=10449549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK543974AA DK138581B (da) | 1973-10-18 | 1974-10-17 | Fremgangsmåde til fremstilling af en virus-underenhedsvaccine stammende fra et æterfølsomt virus. |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5082228A (enExample) |
| AT (1) | AT334524B (enExample) |
| BE (1) | BE821175A (enExample) |
| CA (1) | CA1050886A (enExample) |
| CH (1) | CH611518A5 (enExample) |
| DE (1) | DE2449530C2 (enExample) |
| DK (1) | DK138581B (enExample) |
| FR (1) | FR2248054B1 (enExample) |
| GB (1) | GB1486557A (enExample) |
| IE (1) | IE40187B1 (enExample) |
| IL (1) | IL45870A (enExample) |
| NL (1) | NL181553C (enExample) |
| NO (1) | NO142024C (enExample) |
| SE (1) | SE426439B (enExample) |
| ZA (1) | ZA746398B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK276380A (da) * | 1979-07-09 | 1981-01-10 | Univ Iowa State Res Found Inc | Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis |
| FR2470795A1 (fr) * | 1979-12-07 | 1981-06-12 | Pasteur Institut | Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus |
| FR2475572A1 (fr) * | 1980-02-11 | 1981-08-14 | Pasteur Institut | Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications |
| FR2483779A1 (fr) | 1980-06-05 | 1981-12-11 | Synthelabo | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins |
| DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
| BR0114392A (pt) * | 2000-10-02 | 2003-09-02 | Glaxosmithkline Biolog Sa | Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3519400A (en) * | 1967-01-25 | 1970-07-07 | Atomic Energy Commission | Method of centrifugal separation and recovery of chemical species utilizing a liquid medium |
-
1973
- 1973-10-18 GB GB48685/73A patent/GB1486557A/en not_active Expired
-
1974
- 1974-10-08 ZA ZA00746398A patent/ZA746398B/xx unknown
- 1974-10-17 IE IE2141/74A patent/IE40187B1/xx unknown
- 1974-10-17 CA CA211,654A patent/CA1050886A/en not_active Expired
- 1974-10-17 BE BE149618A patent/BE821175A/xx not_active IP Right Cessation
- 1974-10-17 SE SE7413113A patent/SE426439B/xx unknown
- 1974-10-17 NL NLAANVRAGE7413642,A patent/NL181553C/xx not_active IP Right Cessation
- 1974-10-17 NO NO743758A patent/NO142024C/no unknown
- 1974-10-17 IL IL45870A patent/IL45870A/xx unknown
- 1974-10-17 DE DE2449530A patent/DE2449530C2/de not_active Expired
- 1974-10-17 AT AT835074A patent/AT334524B/de not_active IP Right Cessation
- 1974-10-17 DK DK543974AA patent/DK138581B/da not_active IP Right Cessation
- 1974-10-17 JP JP49119836A patent/JPS5082228A/ja active Pending
- 1974-10-17 CH CH1394974A patent/CH611518A5/xx not_active IP Right Cessation
- 1974-10-18 FR FR7435179A patent/FR2248054B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IE40187L (en) | 1975-04-18 |
| IL45870A0 (en) | 1974-12-31 |
| GB1486557A (en) | 1977-09-21 |
| AU7444974A (en) | 1976-04-29 |
| CA1050886A (en) | 1979-03-20 |
| IL45870A (en) | 1978-03-10 |
| DK543974A (enExample) | 1975-06-16 |
| DE2449530C2 (de) | 1985-08-08 |
| NO142024C (no) | 1980-06-18 |
| DE2449530A1 (de) | 1975-04-30 |
| NO743758L (enExample) | 1975-05-12 |
| NL181553C (nl) | 1987-09-16 |
| FR2248054B1 (enExample) | 1978-07-28 |
| AT334524B (de) | 1976-01-25 |
| CH611518A5 (en) | 1979-06-15 |
| NL181553B (nl) | 1987-04-16 |
| IE40187B1 (en) | 1979-03-28 |
| ZA746398B (en) | 1976-06-30 |
| FR2248054A1 (enExample) | 1975-05-16 |
| BE821175A (fr) | 1975-04-17 |
| NO142024B (no) | 1980-03-10 |
| ATA835074A (de) | 1976-05-15 |
| SE426439B (sv) | 1983-01-24 |
| NL7413642A (nl) | 1975-04-22 |
| JPS5082228A (enExample) | 1975-07-03 |
| DK138581C (enExample) | 1979-03-12 |
| SE7413113L (enExample) | 1975-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK134032B (da) | Fremgangsmåde til fremstilling af en levedygtig stabil virussuspension. | |
| DK136718B (da) | Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyran-9-oner. | |
| DK136719B (da) | Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner. | |
| DK145458C (da) | Fremgangsmaade til fjernelse af ti-urenheder fra et kaolinler | |
| DK135711B (da) | Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer. | |
| DK151993C (da) | Fremgangsmaade til genvinding af bly fra brugte blyakkumulatorer | |
| DK146535C (da) | Fremgangsmaade til fremstilling af 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazin-1,1-dioxid-3-carboxamider | |
| DK150860C (da) | Fremgangsmaade til fremstilling af polylactoner afledt af poly-alfa-hydroxyacrylsyre | |
| DK138581B (da) | Fremgangsmåde til fremstilling af en virus-underenhedsvaccine stammende fra et æterfølsomt virus. | |
| DK139807B (da) | Fremgangsmåde til fremstilling af en rekombinant-influenzavirusstamme. | |
| DK146163C (da) | Fremgangsmaade til regenerering af brugt papir | |
| DK127370B (da) | Fremgangsmåde til fjernelse af en udvalgt komponent fra en gasstrøm. | |
| IT1015316B (it) | Metodo atto a preparare nitrofta limmidi n. sostituite | |
| DK136529B (da) | Analogifremgangsmåde til fremstilling af benzofuranderivater. | |
| NL7501125A (nl) | Extractiebuis voor polyamiden. | |
| DK135169B (da) | Fremgangsmåde til fremstilling af et rent beta-trypsin hidrørende fra svin. | |
| DK143028C (da) | Fremgangsmaade til fremstilling af n5-methyltetrahydro-homofolinsyre ud fra homofolinsyre | |
| DK132447B (da) | Fremgangsmåde til fremstilling af kalvediarrevirusvaccine. | |
| DK137449B (da) | Fremgangsmåde til fremstilling af N,N-diallyldichloracetamid. | |
| DK136775B (da) | Fremgangsmåde til fremstilling af methylcobalamin ud fra et cobalaminderivat. | |
| DK130701B (da) | Fremgangsmåde til udvinding af et insekticid. | |
| DK105426C (da) | Fremgangsmåde til fremstilling af en rabiesvaccine. | |
| DK129244B (da) | Fremgangsmåde til fremstilling af en tyfusvaccine. | |
| DK146598C (da) | Fremgangsmaade til fremstilling af 13beta-alkyl-4-gonen-3,17-dioner | |
| DK131381B (da) | Fremgangsmåde til fremstilling af en metabolit, sesquicillin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |